CSI Market
Sign In | Register

Bluebird Bio Inc (BLUE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BLUE Annual Cash Flow →
This cash flow overview for Bluebird Bio Inc spans from Mar 31 2024 to Mar 31 2025, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
3 Months 		(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Operating Activities
Income-29.07
Depreciation & amortization15.54
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-19.08
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation1.66
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total2.31
Fair Value Of Contingent Consideration Non Cash-
Increase Decrease In Contract With Customer Liability-
Available For Sale Equity Securities Gross Unrealized Loss-
Equity Securities Fv Ni Gain Loss-
Lessee Increase Decrease In Operating Lease Liabilities-
Lessee Increase Decrease In Operating Lease Right Of Use Asset-
Noncash Research And Development Expense Finance Lease-
Noncash Lease Expense4.65
Proceeds From Sale Of Accounts Receivable Operating Activities-
Inventory Excess Valuation Reserves1.01
Transfer Of Invoices To Factor-29.54
Increase Decrease Accrued Interest Payable Under Finance Lease1.42
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable8.99
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-7.28
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets5.74
Other Working Capital0.00
Other Noncash Income (Expense)-0.24
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.44
Discontinued operations0.00
Net Cash flow from Operating Activities-43.44
Investing Activities
Capital Expenditures-0.86
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Payments to Acquire Marketable Securities0.00
Payments for Tenant Improvements0.00
Payments To Acquire Property Plant And Equipment Including Assets Under Financing Lease Obligations-
Payments To Acquire Other Investments And Investment Receivable-
Proceeds From Sales Of Assets Including Adjustments Investing Activities-
Factoring Agreement Cash Receipts Collected-
Factoring Agreement Cash Receipts Collected Net Of Fees3.96
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Proceeds from Sale and Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities3.10
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings54.73
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Payments of Distributions to Affiliates0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-119.51
Payments Of Contingent Purchase Price Consideration-
Proceeds From Public Offering Of Common Stock Net Of Issuance Costs-
Proceeds From Reimbursement Of Tenant Improvements For Financing Lease Obligation-
Proceeds From Reimbursement Of Assets Under Financing Lease Obligation-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents105.94
Finance Lease Principal Payments-28.02
Restricted Cash Current0.04
Restricted Cash Noncurrent13.53
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities26.71
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-44.30
Total Cash Flow-13.63
4 historic quarters locked

Sign in to unlock the full Bluebird Bio Inc cash flow history.

Sign In Create Free Account

About Bluebird Bio Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001293971-25-000014

Figures are derived from filed reports and may be restated. Historical data is subject to revision.